|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
1992-2-6
|
|
pubmed:abstractText |
We studied the joint effect of baseline triglyceride and lipoprotein cholesterol levels on the incidence of cardiac end points in the trial group (n = 4,081) of the Helsinki Heart Study, a 5-year randomized coronary primary prevention trial among dyslipidemic middle-aged men. The relative risks (RR) were calculated using Cox proportional hazards models with a dummy variable technique that allows simultaneous study of subgroup combinations from the placebo and treatment groups.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0009-7322
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
85
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
37-45
|
|
pubmed:dateRevised |
2010-3-24
|
|
pubmed:meshHeading |
pubmed-meshheading:1728471-Adult,
pubmed-meshheading:1728471-Cholesterol, HDL,
pubmed-meshheading:1728471-Cholesterol, LDL,
pubmed-meshheading:1728471-Coronary Disease,
pubmed-meshheading:1728471-Gemfibrozil,
pubmed-meshheading:1728471-Humans,
pubmed-meshheading:1728471-Incidence,
pubmed-meshheading:1728471-Lipids,
pubmed-meshheading:1728471-Male,
pubmed-meshheading:1728471-Middle Aged,
pubmed-meshheading:1728471-Osmolar Concentration,
pubmed-meshheading:1728471-Risk Factors,
pubmed-meshheading:1728471-Triglycerides
|
|
pubmed:year |
1992
|
|
pubmed:articleTitle |
Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatment.
|
|
pubmed:affiliation |
First Department of Medicine, Helsinki University Central Hospital, Finland.
|
|
pubmed:publicationType |
Journal Article
|
